Oliver Lagore Vanvalin Investment Group’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$13.2K Buy
+783
New +$11.9K 0.01% 394
2024
Q4
$13.3K Hold
783
﹤0.01% 409
2024
Q3
$14.2K Hold
783
﹤0.01% 391
2024
Q2
$12.9K Hold
783
﹤0.01% 384
2024
Q1
$11.1K Hold
783
﹤0.01% 406
2023
Q4
$13.5K Hold
783
0.01% 369
2023
Q3
$12K Sell
783
-750
-49% -$13.3K ﹤0.01% 412
2023
Q2
$28.9K Buy
1,533
+1,420
+1,257% +$27.4K 0.01% 323
2023
Q1
$2.18K Hold
113
﹤0.01% 578
2022
Q4
$2.18K Hold
113
﹤0.01% 551
2022
Q3
$2K Hold
113
﹤0.01% 524
2022
Q2
$3K Hold
113
﹤0.01% 466
2022
Q1
$4K Buy
+113
New +$3.56K ﹤0.01% 436

Other funds holding HR

Oliver Lagore Vanvalin Investment Group's HR Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Healthcare Realty (HR) in Q2 2025: 783 shares worth $13.2K. The stake represents 0.01% of the portfolio and ranks #394 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in HR as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in HR in Q1 2022 and has held it in 13 quarters since. The position peaked at $28.9K in Q2 2023. 410 funds tracked by Wall St. Rank hold HR as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 783 shares of Healthcare Realty worth $13.2K as of Q2 2025.
  • Healthcare Realty was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • Healthcare Realty made up 0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #394 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Healthcare Realty in Q1 2022 and has held it in 13 quarters since.
  • Oliver Lagore Vanvalin Investment Group's Healthcare Realty position peaked at $28.9K in Q2 2023.
  • 410 funds tracked by Wall St. Rank held Healthcare Realty as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.